COVID-19 linked to high risk of serious blood clots
Scientists from Umeå Universitet found an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after COVID-19...
New COVID vaccine could prevent omicron and other variants
Scientists from MedUni Vienna found a vaccine developed at to protect against SARS-CoV-2 indicates that it is effective against all SARS-CoV-2 variants known to...
Scientists find why people with blood type O have lower COVID-19 risk
Many studies have found that blood type affects the risk of SARS-CoV-2 infection, with blood Type O being less susceptible and non-O blood types...
Duke study finds the cause of COVID vaccine resistance
Scientists from Duke University found the cause of covid-19 vaccine resistance.
The research is published in PNAS Nexus and was conducted by Terrie Moffitt et...
Scientists find a better way to detect severe COVID-19 early
Scientists from the University of Utah found a family of proteins that is strongly increased in the saliva of patients hospitalized with COVID-19.
The proteins,...
Scientists conduct first human challenge study to show how COVID-19 attacks
A human challenge study also called a controlled human infection trial, is a type of clinical trial for a vaccine or other pharmaceutical involving...
COVID-19 has lingering impacts on brain, scientists find
COVID-19 patients commonly report having headaches, confusion and other neurological symptoms, but doctors don't fully understand how the disease targets the brain during infection.
Scientists...
Common coronavirus infections cannot produce antibodies against COVID-19
Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans.
But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally...
Why diabetes is a big risk factor for severe COVID-19
More than 40% of hospitalized individuals with COVID-19 have diabetes. But why is having diabetes a major risk factor for a more serious COVID-19...
This antiviral drug could eliminate COVID-19 by day 3 of treatment
Scientists found that people taking the new anti-COVID drug molnupiravir eliminate SARS-CoV-2 virus by day three of starting therapy, while many participants who received...